Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Current Hypertension Reports
|
March 11, 2004
Hypertensive renal damage: insights from animal models and clinical relevance
Karen A Griffin, Anil K Bidani
Kidney International
|
May 1, 2009
Angiotensin II type 2 receptor in chronic kidney disease: the good side of angiotensin II?
Karen A Griffin, Anil K Bidani
Nature Reviews. Nephrology
|
December 22, 2010
Chronic kidney disease: blood-pressure targets in chronic kidney disease
Anil K Bidani, Karen A Griffin
Clinical Journal of the American Society of Nephrology : CJASN
|
August 19, 2007
Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade
Karen A Griffin, Anil K Bidani
Hypertension (Dallas, Tex. : 1979)
|
September 29, 2004
Pathophysiology of hypertensive renal damage: implications for therapy
Anil K Bidani, Karen A Griffin
Nature Clinical Practice. Nephrology
|
September 28, 2006
The benefits of renin-angiotensin blockade in hypertension are dependent on blood-pressure lowering
Anil K Bidani, Karen A Griffin
Current Cardiology Reports
|
October 28, 2008
Potential risks of calcium channel blockers in chronic kidney disease
Karen A Griffin, Anil K Bidani
Current Opinion in Nephrology and Hypertension
|
December 26, 2001
Long-term renal consequences of hypertension for normal and diseased kidneys
Anil K Bidani, Karen A Griffin
Hypertension (Dallas, Tex. : 1979)
|
December 3, 2008
Uncritical acceptance of combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease trial results
Karen A Griffin, Anil K Bidani
Journal of the American Society of Hypertension : JASH
|
February 12, 2015
Basic science: hypertensive target organ damage
Anil K Bidani, Karen A Griffin
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Current Hypertension Reports
|
March 11, 2004
Hypertensive renal damage: insights from animal models and clinical relevance
Karen A Griffin, Anil K Bidani
Kidney International
|
May 1, 2009
Angiotensin II type 2 receptor in chronic kidney disease: the good side of angiotensin II?
Karen A Griffin, Anil K Bidani
Nature Reviews. Nephrology
|
December 22, 2010
Chronic kidney disease: blood-pressure targets in chronic kidney disease
Anil K Bidani, Karen A Griffin
Clinical Journal of the American Society of Nephrology : CJASN
|
August 19, 2007
Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade
Karen A Griffin, Anil K Bidani
Hypertension (Dallas, Tex. : 1979)
|
September 29, 2004
Pathophysiology of hypertensive renal damage: implications for therapy
Anil K Bidani, Karen A Griffin
Nature Clinical Practice. Nephrology
|
September 28, 2006
The benefits of renin-angiotensin blockade in hypertension are dependent on blood-pressure lowering
Anil K Bidani, Karen A Griffin
Current Cardiology Reports
|
October 28, 2008
Potential risks of calcium channel blockers in chronic kidney disease
Karen A Griffin, Anil K Bidani
Current Opinion in Nephrology and Hypertension
|
December 26, 2001
Long-term renal consequences of hypertension for normal and diseased kidneys
Anil K Bidani, Karen A Griffin
Hypertension (Dallas, Tex. : 1979)
|
December 3, 2008
Uncritical acceptance of combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease trial results
Karen A Griffin, Anil K Bidani
Journal of the American Society of Hypertension : JASH
|
February 12, 2015
Basic science: hypertensive target organ damage
Anil K Bidani, Karen A Griffin
Page
of 5